BCRX Dividend History & Analysis | N/A Yield

BCRX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.

As of February 2026, BioCryst Pharmaceuticals (BCRX) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap USD Dividend Yield TTM Yield on Cost 5y
ABBV 387,093 M 3.34% 7.54%
AMGN 198,244 M 3.21% 5.93%
GILD 176,133 M 2.79% 5.63%
HLN 46,623 M 1.76% 2.46%
BIM 13,627 M 0.74% 0.75%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap USD Growth Rate Consistency
BTX 1,425 M 134% 95.6%
HLN 46,623 M 30.1% 100%
AMGN 198,244 M 7.84% 100%
BIM 13,627 M 9.76% 96.0%
ABBV 387,093 M 5.98% 100%

Quality Dividend Peers in Biotechnology

AMGN
Amgen
3.21% Yield
GILD
Gilead Sciences
2.79% Yield

BCRX Dividend History: as of February 2026

No dividends paid yet.

BCRX Dividend FAQ

BioCryst Pharmaceuticals (NASDAQ:BCRX) is a U.S. biotech focused on oral small-molecule and injectable protein therapeutics for rare diseases, currently commercializing peramivir (RAPIVAB, RAPIACTA, PERAMIFLU) for acute uncomplicated influenza and ORLADEYO, an oral serine protease inhibitor for hereditary angioedema (HAE).

What is the Dividend Yield of BCRX?

As of February 2026, BCRX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 6.38.

Does BCRX pay a dividend?

As of February 2026 BCRX does not pay a dividend.

How often does BCRX pay dividends?

Over the last 12 months, BCRX has issued dividend payments.

BCRX dividend forecast

Based on historical data, the forecasted dividends per share for BCRX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).
This suggests the dividend will remain relatively stable.

Will BCRX pay dividends in 2026?

The next Ex-Dividend date for BioCryst Pharmaceuticals (BCRX) is currently unknown.

What is the next Ex-Dividend Date for BCRX?

The next Ex-Dividend date for BioCryst Pharmaceuticals (BCRX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of BCRX?

BCRX's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of BCRX?

BCRX's 5-Year Yield on Cost is -%. If you bought BCRX's shares at 10.25 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of BCRX?

BCRX Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does BCRX have a good Dividend Yield?

BCRX`s % Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of BCRX?

The Dividend Payout Ratio of BCRX is unknown.

What is the Dividend Rating of BCRX?

BCRX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

BCRX Outstanding Shares Analysis

What is the Trend in BCRX's Outstanding Shares?

BioCryst Pharmaceuticals's outstanding shares have increased by approximately 4.49% annually over the past 3 years (Trend Reliability: 100.0%).

Watch carefully: The company is issuing new shares, diluting existing shareholders. Dividend growth may lag earnings growth as payouts are spread across more shares.

Has BCRX ever had a Stock Split?

No stock splits on record. The share count changes shown above reflect buybacks, new issuance, or employee compensation rather than structural splits.

Year Number of Shares Annual Growth Rate
1994 7,837,800
1995 9,500,000 +21.21%
1996 13,478,300 +41.88%
1997 13,636,400 +1.17%
1998 15,000,000 +10%
1999 18,961,300 +26.41%
2000 17,539,000 -7.5%
2001 17,627,000 +0.5%
2002 17,663,000 +0.2%
2003 19,587,000 +10.89%
2004 23,620,000 +20.59%
2005 28,938,000 +22.51%
2006 29,274,000 +1.16%
2007 38,059,000 +30.01%
2008 38,204,000 +0.38%
2009 43,925,000 +14.97%
2010 44,987,000 +2.42%
2011 47,105,000 +4.71%
2012 50,883,000 +8.02%
2013 59,091,000 +16.13%
2014 71,867,000 +21.62%
2015 73,345,000 +2.06%
2016 73,764,000 +0.57%
2017 98,402,000 +33.4%
2018 109,802,000 +11.59%
2019 131,303,000 +19.58%
2020 176,618,000 +34.51%
2021 181,843,000 +2.96%
2022 186,922,000 +2.79%
2023 201,409,000 +7.75%
2024 207,381,000 +2.97%
2025 219,885,000 +6.03%

Key Metric Definitions

Dividend Yield
Annual dividend per share divided by current share price.
Payout Ratio
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Payout FCF
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Growth Rate (CAGR)
Compound annual growth rate of dividends over the last 5 years.
Consistency
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Yield on Cost
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Streak
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Dividend Rating
Proprietary score (0-100) combining yield, growth, safety and consistency.

Last update: 2026-01-30 14:21